Page last updated: 2024-11-05

zonisamide and Bulimia

zonisamide has been researched along with Bulimia in 2 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.

Research Excerpts

ExcerptRelevanceReference
"Compared with placebo, zonisamide was associated with a significantly greater rate of reduction in binge eating episode frequency (p = ."9.12Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. ( D'Alessio, DA; Guerdjikova, AI; Hudson, JI; Keck, PE; Kotwal, R; Lake, KA; McElroy, SL; Nelson, EB; Welge, JA, 2006)
"Compared with placebo, zonisamide was associated with a significantly greater rate of reduction in binge eating episode frequency (p = ."5.12Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. ( D'Alessio, DA; Guerdjikova, AI; Hudson, JI; Keck, PE; Kotwal, R; Lake, KA; McElroy, SL; Nelson, EB; Welge, JA, 2006)
"Zonisamide is a novel antiepileptic drug associated with weight loss."2.71Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial. ( Hudson, JI; Keck, PE; Kotwal, R; McElroy, SL; Nelson, EB, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McElroy, SL2
Kotwal, R2
Hudson, JI2
Nelson, EB2
Keck, PE2
Guerdjikova, AI1
Welge, JA1
Lake, KA1
D'Alessio, DA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity: A Single Center, Double-Blind, Placebo-controlled, Flexible-Dose Study in Outpatients[NCT00221442]Phase 360 participants (Actual)Interventional2005-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for zonisamide and Bulimia

ArticleYear
Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:1

    Topics: Administration, Oral; Adult; Anticonvulsants; Body Weight; Bulimia; Female; Humans; Isoxazoles; Male

2004
Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:12

    Topics: Adult; Anticonvulsants; Body Mass Index; Bulimia; Dose-Response Relationship, Drug; Double-Blind Met

2006